Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin. (December 2021) - Celio, L.; Cortinovis, D.; Cogoni, A.A.; Cavanna, L.; Martelli, O.; Carnio, S.; Collovà, E.; Bertolini, F.; Petrelli, F.; Cassano, A.; Chiari, R.; Zanelli, F.; et al.